LY 2784544
|
|
LY 2784544 Eigenschaften
- Dichte
- 1.45
- storage temp.
- Store at -20°C
- L?slichkeit
- ≥23.5 mg/mL in DMSO; insoluble in H2O; ≥5.65 mg/mL in EtOH with gentle warming and ultrasonic
- Aggregatzustand
- solid
- pka
- 14.12±0.10(Predicted)
- Farbe
- Light yellow to yellow
Sicherheit
LY 2784544 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
LY2784544 is a JAK2 inhibitor. LY2784544 may be used as a potential treatment for patients with myeloproliferative neoplasm.LY 2784544 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
LY 2784544 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 164)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
Shandong Risen-Sun Pharmaceutical Co., Ltd | +86-15552509998 +86-15621883869 |
liutf@jewim.com.cn | China | 251 | 58 |
Apeloa production Co.,Limited | +8619933239880 |
admin@apcl.com.cn | China | 861 | 58 |
Capot Chemical Co.,Ltd. | +86-(0)57185586718 +86-13336195806 |
sales@capot.com | China | 29793 | 60 |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 |
ivan@atkchemical.com | China | 32965 | 60 |
career henan chemical co | +86-0371-86658258 +8613203830695 |
sales@coreychem.com | China | 29879 | 58 |
Biochempartner | 0086-13720134139 |
candy@biochempartner.com | CHINA | 965 | 58 |
Hubei xin bonus chemical co. LTD | 86-13657291602 |
linda@hubeijusheng.com | CHINA | 22963 | 58 |
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19553 | 58 |
Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 |
sales@chemdad.com | China | 39894 | 58 |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 |
sales@conier.com | China | 49374 | 58 |
- LY2784544(gandotinib)
- 3-(4-Chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[
- 3-(4-chloro-2-fluorobenzyl)-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(morpholinomethyl)imidazo[1,2-b]pyridazin-6-amine
- LY 2784544
- 3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine
- 3-(4-chloro-2-fluorobenzyl)-2-Methyl-N-(3-Methyl-1H-pyrazol-5-yl)-8-(MorpholinoMethyl)iMidazo[1,2-b]pyridazin-6-aMine
- LY2784544/LY-2784544
- IMidazo[1,2-b]pyridazin-6-aMine, 3-[(4-chloro-2-fluorophenyl)Methyl]-2-Methyl-N-(5-Methyl-1H-pyrazol-3-yl)-8-(4-MorpholinylMethyl)-
- LY2874544
- CS-13
- Gandotinib (LY2784544)
- 3-[(4-Chloro-2-fluorophenyl)methyl]-2-methyl-N-(5-methyl-1H-pyrazol-3-yl)-8-(4-morpholinylmethyl)imidazo[1,2-b]pyridazin-6-amine LY 2784544
- Gandotinib LY2784544 LY-2784544
- VEGFR,inhibit,FGFR,LY-2784544,Janus kinase,CD135,FLT3,Cluster of differentiation antigen 135,LY 2784544,Inhibitor,Gandotinib,Fms like tyrosine kinase 3,Vascular endothelial growth factor receptor,JAK,Fibroblast growth factor receptor
- Gandotinib, 10 mM in DMSO
- 1229236-86-5
- C23H25ClFN7O
- Inhibitors
- JAK
- STAT
- Inhibitor
- JAK/STAT